Superb Dx and AIxMed team up to bring AI-driven urine cytology to Superb Dx’s reference lab capabilities, targeting ...
The findings of a new study add to growing evidence that cotesting may offer limited clinical value despite its common use in ...
Under the MOU, Biopticka will be designated as a reference site for AIxMed in Europe, demonstrating the real-world application of AIxURO™ to prospective partners and clients. Supported by AIxMed's ...
Previous studies have indicated that human papillomavirus (HPV) testing as a triage for managing equivocal cytology is cost-effective. The aim of this study was to assess the costs of alternative roll ...
SANTA CLARA, Calif., Oct. 2, 2025 /PRNewswire/ -- AIxMed Inc., a leader in computational cytology and AI-powered diagnostics, and Biopticka Laboratoř s.r.o., the Czech Republic's leading private ...